Requirement for cyclin D3 in germinal center formation and function

Cell Research

Volumn 20, Issue 6, 2010, Pages 631-646

  Peled, Jonathan U ^a   Yu, J Jessica ^a   Venkatesh, Jeganathan ^b   Bi, Enguang ^a   Ding, B Belinda ^a,e   Krupski Downs, Melissa ^a   Shaknovich, Rita ^c   Sicinski, Piotr ^d   Diamond, Betty ^b   Scharff, Matthew D ^a   Ye, B Hilda ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

^e UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

B cell development; Cell cycle; Cyclin D3; Germinal center

Indexed keywords

CYCLIN D3;

ANIMAL; ARTICLE; B LYMPHOCYTE; C57BL MOUSE; CELL DIFFERENTIATION; CYTOLOGY; GENETICS; GERMINAL CENTER; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; LYMPHOID TISSUE; METABOLISM; MOUSE; MOUSE MUTANT; PHYSIOLOGY;

ANIMALS; B-LYMPHOCYTES; CELL DIFFERENTIATION; CYCLIN D3; GERMINAL CENTER; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOID TISSUE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT;

MUS;

EID: 77953291378     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2010.55     Document Type: Article

References (50)

1. Stavnezer J, Guikema JE, Schrader CE. Mechanism and regulation of class switch recombination. Annu Rev Immunol 2008; 26:261-292.
2. Peled JU, Kuang FL, Iglesias-Ussel MD, et al. The biochemistry of somatic hypermutation. Annu Rev Immunol 2008; 26:481-511.
3. Wang Y, Carter RH. CD19 regulates B cell maturation, proliferation, and positive selection in the FDC zone of murine splenic germinal centers. Immunity 2005; 22:749-761.
4. Allen CD, Okada T, Cyster JG. Germinal-center organization and cellular dynamics. Immunity 2007; 27:190-202.
5. Klein U, Dalla-Favera R. Germinal centres: role in B-cell physiology and malignancy. Nat Rev Immunol 2008; 8:22-33.
6. Shaffer AL, Rosenwald A, Hurt EM, et al. Signatures of the immune response. Immunity 2001; 15:375-385.
7. Ci W, Polo JM, Cerchietti L, et al. The BCL6 transcriptional program features repression of multiple oncogenes in primary B-cells and is deregulated in DLBCL. Blood 2009; 113:5536-5548.
8. Yu RY, Wang X, Pixley FJ, et al. BCL-6 negatively regulates macrophage proliferation by suppressing autocrine IL-6 production. Blood 2005; 105:1777-1784.
9. Tourigny MR, Ursini-Siegel J, Lee H, et al. CDK inhibitor p18 (INK4c) is required for the generation of functional plasma cells. Immunity 2002; 17:179-189.
10. Massague J. G1 cell-cycle control and cancer. Nature 2004; 432:298-306.
11. Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 1999; 13:1501-1512.
12. Kozar K, Ciemerych MA, Rebel VI, et al. Mouse development and cell proliferation in the absence of D-Cyclins. Cell 2004; 118:477-491.
13. Sicinska E, Aifantis I, Le Cam L, et al. Requirement for cyclin D3 in lymphocyte development and T cell leukemias. Cancer Cell 2003; 4:451-461.
14. Cooper AB, Sawai CM, Sicinska E, et al. A unique function for cyclin D3 in early B cell development. Nat Immunol 2006; 7:489-497.
15. Sonoki T, Harder L, Horsman DE, et al. Cyclin D3 is a target gene of t(6;14)(p21.1;q32.3) of mature B-cell malignancies. Blood 2001; 98:2837-2844.
16. Filipits M, Jaeger U, Pohl G, et al. Cyclin D3 is a predictive and prognostic factor in diffuse large B-cell lymphoma. Clin Cancer Res 2002; 8:729-733.
17. Hogerkorp CM, Borrebaeck CA. The human CD77- B cell population represents a heterogeneous subset of cells comprising centroblasts, centrocytes, and plasmablasts, prompting phenotypical revision. J Immunol 2006; 177:4341-4349.
18. Doglioni C, Chiarelli C, Macri E, et al. Cyclin D3 expression in normal, reactive and neoplastic tissues. J Pathol 1998; 185:159-166.
19. Teramoto N, Pokrovskaja K, Szekely L, et al. Expression of cyclin D2 and D3 in lymphoid lesions. Int J Cancer 1999; 81:543-550.
20. Shaffer AL, Yu X, He Y, et al. BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. Immunity 2000; 13:199-212.
21. Mataraza JM, Tumang JR, Gumina MR, et al. Disruption of cyclin D3 blocks proliferation of normal B-1a cells, but loss of cyclin D3 is compensated by cyclin D2 in cyclin D3-deficient mice. J Immunol 2006; 177:787-795.
22. Wen L, Brill-Dashoff J, Shinton SA, et al. Evidence of marginal-zone B cell-positive selection in spleen. Immunity 2005; 23:297-308.
23. Casola S, Otipoby KL, Alimzhanov M, et al. B cell receptor signal strength determines B cell fate. Nat Immunol 2004; 5:317-327.
24. Takahashi Y, Dutta PR, Cerasoli DM, Kelsoe G. In situ studies of the primary immune response to (4-Hydroxy-3-Nitrophenyl) Acetyl. V. affinity maturation develops in two stages of clonal selection. J Exp Med 1998; 187:885-895.
25. Wang Y, Brooks SR, Li X, et al. The physiologic role of CD19 cytoplasmic tyrosines. Immunity 2002; 17:501-514.
26. Lam EWF, Glassford J, Banerji L, et al. Cyclin D3 compensates for loss of cyclin D2 in mouse B-lymphocytes activated via the antigen receptor and CD40. J Biol Chem 2000; 275:3479-3484.
27. Ye BH, Cattoretti G, Shen Q, et al. The BCL-6 protooncogene controls germinal-centre formation and Th2- type inflammation. Nat Genet 1997; 16:161-170.
28. Dent AL, Shaffer AL, Yu X, Allman D, Staudt LM. Control of inflammation, cytokine expression, and germinal center formation by BCL-6. Science 1997; 276:589-592.
29. Cattoretti G, Chang CC, Cechova K, et al. BCL-6 protein is expressed in germinal-center B cells. Blood 1995; 86:45-53.
30. Kuppers R, Klein U, Schwering I, et al. Identification of Hodgkin and Reed-Sternberg cell-specific genes by gene expression profiling. J Clin Invest 2003; 111:529-537. (Pubitemid 36228010)
31. Cattoretti G, Pasqualucci L, Ballon G, et al. Deregulated BCL6 expression recapitulates the pathogenesis of human diffuse large B cell lymphomas in mice. Cancer Cell 2005; 7:445-455.
32. Lam EW, Glassford J, Banerji L, et al. Cyclin D3 compensates for loss of cyclin D2 in mouse B-lymphocytes activated via the antigen receptor and CD40. J Biol Chem 2000; 275:3479-3484.
33. Luckey CJ, Bhattacharya D, Goldrath AW, et al. Memory T and memory B cells share a transcriptional program of selfrenewal with long-term hematopoietic stem cells. Proc Natl Acad Sci USA 2006; 103:3304-3309.
34. Tangye SG, Hodgkin PD. Divide and conquer: the importance of cell division in regulating B-cell responses. Immunology 2004; 112:509-520.
35. Toellner KM, Gulbranson-Judge A, Taylor DR, Sze DM, MacLennan IC. Immunoglobulin switch transcript production in vivo related to the site and time of antigen-specific B cell activation. J Exp Med 1996; 183:2303-2312.
36. Benson MJ, Elgueta R, Schpero W, et al. Distinction of the memory B cell response to cognate antigen versus bystander inflammatory signals. J Exp Med 2009; 206:2013-2025.
37. Satyanarayana A, Kaldis P. Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms. Oncogene 2009; 28:2925-2939.
38. Kozar K, Sicinski P. Cell cycle progression without cyclin D-CDK4 and cyclin D-CDK6 complexes. Cell Cycle 2005; 4:388-391.
39. Mullany LK, White P, Hanse EA, et al. Distinct proliferative and transcriptional effects of the D-type cyclins in vivo. Cell Cycle 2008; 7:2215-2224.
40. Lamb J, Ramaswamy S, Ford HL, et al. A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer. Cell 2003; 114:323-334.
41. Peterson LF, Boyapati A, Ranganathan V, et al. The hematopoietic transcription factor AML1 (RUNX1) is negatively regulated by the cell cycle protein cyclin D3. Mol Cell Biol 2005; 25:10205-10219.
42. Olshavsky NA, Groh EM, Comstock CE, et al. Cyclin D3 action in androgen receptor regulation and prostate cancer. Oncogene 2008; 27:3111-3121.
43. Johnston RJ, Poholek AC, Ditoro D, et al. Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation. Science 2009; 325:1006-1010.
44. Nurieva RI, Chung Y, Martinez GJ, et al. Bcl6 mediates the development of T follicular helper cells. Science 2009; 325:1001-1005.
45. Yu D, Rao S, Tsai LM, et al. The Transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment. Immunity 2009; 31:457-468.
46. Meyer-Bahlburg A, Khim S, Rawlings DJ. B cell intrinsic TLR signals amplify but are not required for humoral immunity. J Exp Med 2007; 204:3095-3101.
47. Mandal M, Powers SE, Ochiai K, et al. Ras orchestrates exit from the cell cycle and light-chain recombination during early B cell development. Nat Immunol 2009; 10:1110-1117.
48. Cattoretti G, Shaknovich R, Smith PM, et al. Stages of germinal center transit are defined by B cell transcription factor coexpression and relative abundance. J Immunol 2006; 177:6930-6939.
49. Bardwell PD, Woo CJ, Wei K, et al. Altered somatic hypermutation and reduced class-switch recombination in exonuclease 1-mutant mice. Nat Immunol 2004; 5:224-229.
50. Mendez LM, Polo JM, Yu JJ, et al. CtBP is an essential corepressor for BCL6 autoregulation. Mol Cell Biol 2008; 28:2175-2186.